Cellular and molecular mechanisms of renal fibrosis

[1]  F. Eitner,et al.  The PDGF family in renal fibrosis , 2012, Pediatric Nephrology.

[2]  J. Duffield,et al.  The origin of interstitial myofibroblasts in chronic kidney disease , 2012, Pediatric Nephrology.

[3]  F. Strutz,et al.  Fibrosis and evidence for epithelial‐mesenchymal transition in the kidneys of patients with staghorn calculi , 2011, BJU international.

[4]  Mitsuo Kato,et al.  A microRNA circuit mediates transforming growth factor-β1 autoregulation in renal glomerular mesangial cells. , 2011, Kidney international.

[5]  C. Kurts,et al.  Homeostatic and pathogenic role of renal dendritic cells. , 2011, Kidney international.

[6]  S. Quaggin,et al.  Scar wars: mapping the fate of epithelial-mesenchymal-myofibroblast transition. , 2011, Kidney international.

[7]  P. Boor,et al.  Chronic kidney disease growth factors in renal fibrosis , 2011, Clinical and experimental pharmacology & physiology.

[8]  P. Mattei,et al.  An orally active chemokine receptor CCR2 antagonist prevents glomerulosclerosis and renal failure in type 2 diabetes. , 2011, Kidney international.

[9]  A. Phillips,et al.  Monocytes induce proximal tubular epithelial–mesenchymal transition through NF‐kappa B dependent upregulation of ICAM‐1 , 2011, Journal of cellular biochemistry.

[10]  S. Meran,et al.  Fibroblasts and myofibroblasts in renal fibrosis , 2011, International journal of experimental pathology.

[11]  Y. Gorin,et al.  Myofibroblast differentiation during fibrosis: role of NAD(P)H oxidases. , 2011, Kidney international.

[12]  H. Lan,et al.  Chemokines in renal injury. , 2011, Journal of the American Society of Nephrology : JASN.

[13]  J. Duffield,et al.  Mechanisms of fibrosis: the role of the pericyte , 2011, Current opinion in nephrology and hypertension.

[14]  A. Hertig,et al.  Epithelial to mesenchymal transition as a biomarker in renal fibrosis: are we ready for the bedside? , 2011, Fibrogenesis & tissue repair.

[15]  J. Thiery,et al.  SnapShot: The Epithelial-Mesenchymal Transition , 2011, Cell.

[16]  J. Duffield,et al.  Origin of new cells in the adult kidney: results from genetic labeling techniques. , 2011, Kidney international.

[17]  U. Panzer,et al.  Kidney Dendritic Cells Become Pathogenic during Crescentic Glomerulonephritis with Proteinuria. , 2011, Journal of the American Society of Nephrology : JASN.

[18]  J. Duffield.  Macrophages in kidney repair and regeneration. , 2011, Journal of the American Society of Nephrology : JASN.

[19]  C. Kuo,et al.  Targeting endothelium-pericyte cross talk by inhibiting VEGF receptor signaling attenuates kidney microvascular rarefaction and fibrosis. , 2011, The American journal of pathology.

[20]  M. Le Hir,et al.  Epithelial-mesenchymal transition (EMT) in kidney fibrosis: fact or fantasy? , 2011, The Journal of clinical investigation.

[21]  S. Nagao,et al.  Epithelial-to-mesenchymal transition in cyst lining epithelial cells in an orthologous PCK rat model of autosomal-recessive polycystic kidney disease. , 2011, American journal of physiology. Renal physiology.

[22]  K. Suszták,et al.  The story of Notch and chronic kidney disease , 2011, Current opinion in nephrology and hypertension.

[23]  G. Navis,et al.  Vitamin D in chronic kidney disease: new potential for intervention. , 2011, Current drug targets.

[24]  Youhua Liu,et al.  Blockade of Wnt/β-catenin signaling by paricalcitol ameliorates proteinuria and kidney injury. , 2011, Journal of the American Society of Nephrology : JASN.

[25]  R. Touyz,et al.  Reactive oxygen species and vascular biology: implications in human hypertension , 2011, Hypertension Research.

[26]  D. Harris,et al.  Macrophages in renal disease. , 2011, Journal of the American Society of Nephrology : JASN.

[27]  S. Kaneko,et al.  Involvement of bone-marrow-derived cells in kidney fibrosis , 2011, Clinical and Experimental Nephrology.

[28]  Tsutomu Inoue,et al.  Fibroblast expression of an IκB dominant-negative transgene attenuates renal fibrosis. , 2010, Journal of the American Society of Nephrology : JASN.

[29]  H. Parving,et al.  Selective vitamin D receptor activation with paricalcitol for reduction of albuminuria in patients with type 2 diabetes (VITAL study): a randomised controlled trial , 2010, The Lancet.

[30]  Burden of CKD, proteinuria, and cardiovascular risk among Chinese, Mongolian, and Nepalese participants in the International Society of Nephrology screening programs. , 2010, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[31]  P. Boor,et al.  Renal fibrosis: novel insights into mechanisms and therapeutic targets , 2010, Nature Reviews Nephrology.

[32]  M. Gessler,et al.  Epithelial Notch signaling regulates interstitial fibrosis development in the kidneys of mice and humans. , 2010, The Journal of clinical investigation.

[33]  Xuebing Ding,et al.  TGF-β-induced MiR-491-5p Expression Promotes Par-3 Degradation in Rat Proximal Tubular Epithelial Cells* , 2010, The Journal of Biological Chemistry.

[34]  Merlin C. Thomas,et al.  miR-200a Prevents Renal Fibrogenesis Through Repression of TGF-β2 Expression , 2010, Diabetes.

[35]  M. Tang,et al.  Transforming growth factor-{beta}1 induces Smad3-dependent {beta}1 integrin gene expression in epithelial-to-mesenchymal transition during chronic tubulointerstitial fibrosis. , 2010, The American journal of pathology.

[36]  Sakae Tanaka,et al.  tPA activates LDL receptor-related protein 1-mediated mitogenic signaling involving the p90RSK and GSK3beta pathway. , 2010, The American journal of pathology.

[37]  M. Nangaku,et al.  The suffocating kidney: tubulointerstitial hypoxia in end-stage renal disease , 2010, Nature Reviews Nephrology.

[38]  Mingxia Xiong,et al.  Mice lacking the matrix metalloproteinase-9 gene reduce renal interstitial fibrosis in obstructive nephropathy. , 2010, American journal of physiology. Renal physiology.

[39]  W. Mars,et al.  tPA is a potent mitogen for renal interstitial fibroblasts: role of beta1 integrin/focal adhesion kinase signaling. , 2010, The American journal of pathology.

[40]  L. Foster,et al.  Integrin-Linked Kinase Is a Functional Mn2+-Dependent Protein Kinase that Regulates Glycogen Synthase Kinase-3β (GSK-3β) Phosphorylation , 2010, PloS one.

[41]  Hiroshi Yamamoto,et al.  Blockade of Endothelial-Mesenchymal Transition by a Smad3 Inhibitor Delays the Early Development of Streptozotocin-Induced Diabetic Nephropathy , 2010, Diabetes.

[42]  Youhua Liu,et al.  Inhibition of integrin-linked kinase blocks podocyte epithelial-mesenchymal transition and ameliorates proteinuria. , 2010, Kidney international.

[43]  N. Sheerin,et al.  Pivotal role of CD4+ T cells in renal fibrosis following ureteric obstruction. , 2010, Kidney international.

[44]  R. Gebhardt,et al.  Cardiovascular , Pulmonary and Renal Pathology Tubular Overexpression of Transforming Growth Factor-1 Induces Autophagy and Fibrosis but Not Mesenchymal Transition of Renal Epithelial Cells , 2010 .

[45]  J. Duffield,et al.  Resolved: EMT produces fibroblasts in the kidney. , 2010, Journal of the American Society of Nephrology : JASN.

[46]  K. Lai,et al.  Essential role for Smad3 in angiotensin II‐induced tubular epithelial–mesenchymal transition , 2010, The Journal of pathology.

[47]  J. Bertram,et al.  Review: Endothelial‐myofibroblast transition, a new player in diabetic renal fibrosis , 2010, Nephrology.

[48]  Youhua Liu,et al.  Opposite Action of Peroxisome Proliferator-activated Receptor-γ in Regulating Renal Inflammation , 2010, The Journal of Biological Chemistry.

[49]  R. Bucala,et al.  Fibrocytes in health and disease. , 2010, Experimental hematology.

[50]  M. Kahn,et al.  Plasminogen Activator Inhibitor-1 Is a Transcriptional Target of the Canonical Pathway of Wnt/β-Catenin Signaling* , 2010, The Journal of Biological Chemistry.

[51]  V. D’Agati,et al.  RAGE and the pathogenesis of chronic kidney disease , 2010, Nature Reviews Nephrology.

[52]  D. Harris,et al.  IL-10/TGF-beta-modified macrophages induce regulatory T cells and protect against adriamycin nephrosis. , 2010, Journal of the American Society of Nephrology : JASN.

[53]  J. Duffield.  Macrophages and immunologic inflammation of the kidney. , 2010, Seminars in nephrology.

[54]  Merlin C. Thomas,et al.  The molecular mediators of type 2 epithelial to mesenchymal transition (EMT) and their role in renal pathophysiology , 2010, Expert Reviews in Molecular Medicine.

[55]  H. Anders,et al.  Targeting the recruitment of monocytes and macrophages in renal disease. , 2010, Seminars in nephrology.

[56]  J. Hughes,et al.  Macrophages and renal fibrosis. , 2010, Seminars in nephrology.

[57]  R. Kalluri,et al.  Methylation determines fibroblast activation and fibrogenesis in the kidney , 2010, Nature Medicine.

[58]  Li Yang,et al.  Epithelial cell cycle arrest in G2/M mediates kidney fibrosis after injury , 2010, Nature Medicine.

[59]  Hui Geng,et al.  Acute kidney injury: a springboard for progression in chronic kidney disease. , 2010, American journal of physiology. Renal physiology.

[60]  Ling Li,et al.  Autophagy is a component of epithelial cell fate in obstructive uropathy. , 2010, The American journal of pathology.

[61]  S. Borkan,et al.  HSP72 inhibits Smad3 activation and nuclear translocation in renal epithelial-to-mesenchymal transition. , 2010, Journal of the American Society of Nephrology : JASN.

[62]  T. Uzu,et al.  Calorie restriction enhances cell adaptation to hypoxia through Sirt1-dependent mitochondrial autophagy in mouse aged kidney. , 2010, The Journal of clinical investigation.

[63]  Stefano Piccolo,et al.  MicroRNA control of signal transduction , 2010, Nature Reviews Molecular Cell Biology.

[64]  Z. Dong,et al.  Autophagy is a renoprotective mechanism during in vitro hypoxia and in vivo ischemia-reperfusion injury. , 2010, The American journal of pathology.

[65]  A. Phillips,et al.  Bone morphogenetic protein-7 inhibits proximal tubular epithelial cell Smad3 signaling via increased SnoN expression. , 2010, The American journal of pathology.

[66]  S. Bachmann,et al.  Hypoxia-inducible factor-2alpha-expressing interstitial fibroblasts are the only renal cells that express erythropoietin under hypoxia-inducible factor stabilization. , 2010, Kidney international.

[67]  Kjetil Boye,et al.  S100A4 and metastasis: a small actor playing many roles. , 2010, The American journal of pathology.

[68]  V. D’Agati,et al.  Advanced glycation end-products: implications for diabetic and non-diabetic nephropathies. , 2010, Diabetes & metabolism.

[69]  Youhua Liu.  New insights into epithelial-mesenchymal transition in kidney fibrosis. , 2010, Journal of the American Society of Nephrology : JASN.

[70]  Arnoud Sonnenberg,et al.  Integrin–TGF‐β crosstalk in fibrosis, cancer and wound healing , 2010, EMBO reports.

[71]  Xiao-ming Meng,et al.  miR-192 Mediates TGF- /Smad3-Driven Renal Fibrosis , 2010 .

[72]  W. Mars,et al.  Role of 1 Integrin/Focal Adhesion Kinase Signaling , 2010 .

[73]  D. Chi,et al.  Endothelial cell biology: role in the inflammatory response. , 2010, Advances in clinical chemistry.

[74]  A. McMahon,et al.  Fate tracing reveals the pericyte and not epithelial origin of myofibroblasts in kidney fibrosis. , 2010, The American journal of pathology.

[75]  Carl Nathan,et al.  Nonresolving Inflammation , 2010, Cell.

[76]  M. T. Grande,et al.  Role of inflammation in túbulo-interstitial damage associated to obstructive nephropathy , 2010, Journal of Inflammation.

[77]  P. Gaffney,et al.  Inhibitor of Differentiation 1 Contributes to Head and Neck Squamous Cell Carcinoma Survival via the NF-κB/Survivin and Phosphoinositide 3-Kinase/Akt Signaling Pathways , 2009, Clinical Cancer Research.

[78]  J. Qin,et al.  The pseudoactive site of ILK is essential for its binding to alpha-Parvin and localization to focal adhesions. , 2009, Molecular cell.

[79]  M. Dockrell,et al.  Connective Tissue Growth Factor-(CTGF, CCN2) – A Marker, Mediator and Therapeutic Target for Renal Fibrosis , 2009, Nephron Experimental Nephrology.

[80]  Youhua Liu,et al.  Combination therapy with paricalcitol and trandolapril reduces renal fibrosis in obstructive nephropathy. , 2009, Kidney international.

[81]  M. Little,et al.  Loss of renal microvascular integrity in postnatal Crim1 hypomorphic transgenic mice. , 2009, Kidney international.

[82]  F. Hou,et al.  Accumulation of advanced oxidation protein products induces podocyte apoptosis and deletion through NADPH-dependent mechanisms. , 2009, Kidney international.

[83]  R. Huang,et al.  Epithelial-Mesenchymal Transitions in Development and Disease , 2009, Cell.

[84]  J. Duffield,et al.  Bone Marrow Ly6Chigh Monocytes Are Selectively Recruited to Injured Kidney and Differentiate into Functionally Distinct Populations1 , 2009, The Journal of Immunology.

[85]  K. Schmidbauer,et al.  CD4+ T cells control the differentiation of Gr1+ monocytes into fibrocytes , 2009, Proceedings of the National Academy of Sciences.

[86]  R. Gomer,et al.  Identification of Markers that Distinguish Monocyte-Derived Fibrocytes from Monocytes, Macrophages, and Fibroblasts , 2009, PloS one.

[87]  A. Bradshaw.  The role of SPARC in extracellular matrix assembly , 2009, Journal of Cell Communication and Signaling.

[88]  K. Kimura,et al.  Epithelial-mesenchymal transition as a potential explanation for podocyte depletion in diabetic nephropathy. , 2009, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[89]  J. Bertram,et al.  Endothelial-myofibroblast transition contributes to the early development of diabetic renal interstitial fibrosis in streptozotocin-induced diabetic mice. , 2009, The American journal of pathology.

[90]  M. Crow,et al.  Foxp3+ regulatory T cells participate in repair of ischemic acute kidney injury. , 2009, Kidney international.

[91]  H. Lan,et al.  Angiotensin II Induces Connective Tissue Growth Factor and Collagen I Expression via Transforming Growth Factor–&bgr;–Dependent and –Independent Smad Pathways: The Role of Smad3 , 2009, Hypertension.

[92]  S. Holdsworth,et al.  IL-1RI deficiency ameliorates early experimental renal interstitial fibrosis. , 2009, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[93]  J. Bonventre,et al.  HIF in kidney disease and development. , 2009, Journal of the American Society of Nephrology.

[94]  D. Stolz,et al.  Inhibition of integrin-linked kinase attenuates renal interstitial fibrosis. , 2009, Journal of the American Society of Nephrology : JASN.

[95]  M. Nieto,et al.  Inflammation and EMT: an alliance towards organ fibrosis and cancer progression , 2009, EMBO molecular medicine.

[96]  J. Dominguez,et al.  Postischemic inflammatory syndrome: a critical mechanism of progression in diabetic nephropathy. , 2009, American journal of physiology. Renal physiology.

[97]  Linghong Huang,et al.  Transglutaminase inhibition ameliorates experimental diabetic nephropathy. , 2009, Kidney international.

[98]  J. Geddes,et al.  What is a randomised controlled trial? , 2009, Epidemiologia e Psichiatria Sociale.

[99]  Raghu Kalluri,et al.  The basics of epithelial-mesenchymal transition. , 2009, The Journal of clinical investigation.

[100]  M. T. Grande,et al.  Fibroblast activation and myofibroblast generation in obstructive nephropathy , 2009, Nature Reviews Nephrology.

[101]  T. Hewitson.  Renal tubulointerstitial fibrosis: common but never simple. , 2009, American journal of physiology. Renal physiology.

[102]  M. Nieto,et al.  Epithelial-mesenchymal transitions: the importance of changing cell state in development and disease. , 2009, The Journal of clinical investigation.

[103]  Suimin Qiu,et al.  Stabilization of snail by NF-kappaB is required for inflammation-induced cell migration and invasion. , 2009, Cancer cell.

[104]  J. Floege,et al.  Kidney dendritic cell activation is required for progression of renal disease in a mouse model of glomerular injury. , 2009, The Journal of clinical investigation.

[105]  S. Weiss,et al.  Mesenchymal cells reactivate Snail1 expression to drive three-dimensional invasion programs , 2009, The Journal of cell biology.

[106]  R. Fässler,et al.  Mechanisms that regulate adaptor binding to β-integrin cytoplasmic tails , 2009, Journal of Cell Science.

[107]  B. Eyden.  Fibronexus Junctions Associated with In Vivo Human Endothelium , 2009, Ultrastructural pathology.

[108]  Youhua Liu,et al.  Wnt/ -Catenin Signaling Promotes Renal Interstitial Fibrosis , 2009 .

[109]  G. Remuzzi,et al.  Proteasomal processing of albumin by renal dendritic cells generates antigenic peptides. , 2009, Journal of the American Society of Nephrology : JASN.

[110]  Rajit K. Basu,et al.  TGF-beta signal transduction in chronic kidney disease. , 2009, Frontiers in bioscience.

[111]  N. Yorioka,et al.  PPAR-γ agonist attenuates renal interstitial fibrosis and inflammation through reduction of TGF-β , 2009, Laboratory Investigation.

[112]  H. Lan,et al.  Angiotensin II Induces Connective Tissue Growth Factor and Collagen I Expression via Transforming Growth Factor–&bgr;–Dependent and –Independent Smad Pathways: The Role of Smad3 , 2009, Hypertension.

[113]  D. Brenner,et al.  Pericytes and perivascular fibroblasts are the primary source of collagen-producing cells in obstructive fibrosis of the kidney. , 2008, The American journal of pathology.

[114]  S. Holdsworth,et al.  Role of mast cells in progressive renal diseases. , 2008, Journal of the American Society of Nephrology : JASN.

[115]  Raghu Kalluri,et al.  Fibroblasts in kidney fibrosis emerge via endothelial-to-mesenchymal transition. , 2008, Journal of the American Society of Nephrology : JASN.

[116]  R. Nusse,et al.  Wnt signaling mediates self-organization and axis formation in embryoid bodies. , 2008, Cell stem cell.

[117]  H. van Goor,et al.  Macrophage diversity in renal injury and repair. , 2008, The Journal of clinical investigation.

[118]  J. Norman,et al.  Chronic hypoxia as a mechanism of progression of chronic kidney diseases: from hypothesis to novel therapeutics. , 2008, Kidney international.

[119]  G. Melino,et al.  Tissue transglutaminase contributes to interstitial renal fibrosis by favoring accumulation of fibrillar collagen through TGF-beta activation and cell infiltration. , 2008, The American journal of pathology.

[120]  A. Ortiz,et al.  Angiotensin II activates the Smad pathway during epithelial mesenchymal transdifferentiation. , 2008, Kidney international.

[121]  Youhua Liu,et al.  Paricalcitol inhibits renal inflammation by promoting vitamin D receptor-mediated sequestration of NF-kappaB signaling. , 2008, Journal of the American Society of Nephrology : JASN.

[122]  M. Grigorian,et al.  Metastasis-inducing S100A4 protein: implication in non-malignant human pathologies. , 2008, Current molecular medicine.

[123]  E. Sage,et al.  The Copper Binding Domain of SPARC Mediates Cell Survival in Vitro via Interaction with Integrin β1 and Activation of Integrin-linked Kinase* , 2008, Journal of Biological Chemistry.

[124]  Z. Guo,et al.  Advanced oxidation protein products activate vascular endothelial cells via a RAGE-mediated signaling pathway. , 2008, Antioxidants & redox signaling.

[125]  N. Brousse,et al.  Early epithelial phenotypic changes predict graft fibrosis. , 2008, Journal of the American Society of Nephrology : JASN.

[126]  G. Michalopoulos,et al.  Hepatocyte growth factor exerts its anti-inflammatory action by disrupting nuclear factor-kappaB signaling. , 2008, The American journal of pathology.

[127]  M. Le Hir,et al.  The renal cortical interstitium: morphological and functional aspects , 2008, Histochemistry and Cell Biology.

[128]  Y. Wang,et al.  By homing to the kidney, activated macrophages potently exacerbate renal injury. , 2008, The American journal of pathology.

[129]  R. Gomer,et al.  Pivotal Advance: Th‐1 cytokines inhibit, and Th‐2 cytokines promote fibrocyte differentiation , 2008, Journal of leukocyte biology.

[130]  Kebin Hu,et al.  Novel actions of tissue-type plasminogen activator in chronic kidney disease. , 2008, Frontiers in bioscience : a journal and virtual library.

[131]  S. Kaneko,et al.  The renin–angiotensin system contributes to renal fibrosis through regulation of fibrocytes , 2008, Journal of hypertension.

[132]  Z. Guo,et al.  Advanced oxidation protein products promote inflammation in diabetic kidney through activation of renal nicotinamide adenine dinucleotide phosphate oxidase. , 2008, Endocrinology.

[133]  R. Natarajan,et al.  Proinflammatory Effects of Advanced Lipoxidation End Products in Monocytes , 2008, Diabetes.

[134]  Ling Lin,et al.  tPA protects renal interstitial fibroblasts and myofibroblasts from apoptosis. , 2008, Journal of the American Society of Nephrology : JASN.

[135]  Luxia Zhang,et al.  Prevalence and factors associated with CKD: a population study from Beijing. , 2008, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[136]  Youhua Liu,et al.  Epithelial-to-mesenchymal transition is a potential pathway leading to podocyte dysfunction and proteinuria. , 2008, The American journal of pathology.

[137]  J. Iredale,et al.  Galectin-3 expression and secretion links macrophages to the promotion of renal fibrosis. , 2008, The American journal of pathology.

[138]  A. Nègre-Salvayre,et al.  Advanced lipid peroxidation end products in oxidative damage to proteins. Potential role in diseases and therapeutic prospects for the inhibitors , 2008, British journal of pharmacology.

[139]  Hyoung-Kyu kim,et al.  Macrophages contribute to the development of renal fibrosis following ischaemia/reperfusion-induced acute kidney injury. , 2007, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[140]  G. Michalopoulos,et al.  Hepatocyte Growth Factor Exerts Its Anti-Inflammatory Action by Disrupting Nuclear Factor- B Signaling , 2008 .

[141]  C. Alpers,et al.  A new look at platelet-derived growth factor in renal disease. , 2008, Journal of the American Society of Nephrology : JASN.

[142]  Kebin Hu,et al.  Tissue-type plasminogen activator promotes murine myofibroblast activation through LDL receptor-related protein 1-mediated integrin signaling. , 2007, The Journal of clinical investigation.

[143]  K. Kimura,et al.  Hypoxia promotes fibrogenesis in vivo via HIF-1 stimulation of epithelial-to-mesenchymal transition. , 2007, The Journal of clinical investigation.

[144]  L. Wen,et al.  Treatment with CD20-specific antibody prevents and reverses autoimmune diabetes in mice. , 2007, The Journal of clinical investigation.

[145]  J. Coresh,et al.  Prevalence of chronic kidney disease in the United States. , 2007, JAMA.

[146]  P. Nelson,et al.  Dendritic cells in the kidney. , 2007, Journal of the American Society of Nephrology : JASN.

[147]  Youhua Liu,et al.  PINCH-1 promotes tubular epithelial-to-mesenchymal transition by interacting with integrin-linked kinase. , 2007, Journal of the American Society of Nephrology : JASN.

[148]  Bicheng Liu,et al.  Role of ERK1/2 and PI3-K in the regulation of CTGF-induced ILK expression in HK-2 cells. , 2007, Clinica chimica acta; international journal of clinical chemistry.

[149]  Giulio Gabbiani,et al.  The myofibroblast: one function, multiple origins. , 2007, The American journal of pathology.

[150]  E. Bottinger.  TGF-β in renal injury and disease , 2007 .

[151]  L. Dworkin,et al.  Long-term, high-dosage candesartan suppresses inflammation and injury in chronic kidney disease: nonhemodynamic renal protection. , 2007, Journal of the American Society of Nephrology : JASN.

[152]  T. Wynn,et al.  Common and unique mechanisms regulate fibrosis in various fibroproliferative diseases. , 2007, The Journal of clinical investigation.

[153]  S. Dedhar,et al.  Tubular epithelial cell dedifferentiation is driven by the helix-loop-helix transcriptional inhibitor Id1. , 2007, Journal of the American Society of Nephrology : JASN.

[154]  B. Hinz,et al.  One Function, Multiple Origins , 2007 .

[155]  M. Hori,et al.  Smooth Muscle α-Actin Deficiency in Myofibroblasts Leads to Enhanced Renal Tissue Fibrosis* , 2006, Journal of Biological Chemistry.

[156]  Youhua Liu,et al.  Paricalcitol attenuates renal interstitial fibrosis in obstructive nephropathy. , 2006, Journal of the American Society of Nephrology : JASN.

[157]  M. Nieto,et al.  Snail activation disrupts tissue homeostasis and induces fibrosis in the adult kidney , 2006, The EMBO journal.

[158]  H. Liou,et al.  Id1 Potentiates NF-κB Activation upon T Cell Receptor Signaling* , 2006, Journal of Biological Chemistry.

[159]  F Verrecchia,et al.  [Cellular and molecular mechanisms of fibrosis]. , 2006, Annales de pathologie.

[160]  F. Strutz,et al.  Renal fibroblasts and myofibroblasts in chronic kidney disease. , 2006, Journal of the American Society of Nephrology : JASN.

[161]  M. D. de Caestecker,et al.  Renal bone morphogenetic protein-7 protects against diabetic nephropathy. , 2006, Journal of the American Society of Nephrology : JASN.

[162]  L. Dworkin,et al.  Anti-inflammatory effect of hepatocyte growth factor in chronic kidney disease: targeting the inflamed vascular endothelium. , 2006, Journal of the American Society of Nephrology : JASN.

[163]  A. Pollock,et al.  Matrix metalloproteinase 2 and basement membrane integrity: a unifying mechanism for progressive renal injury , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[164]  R. Monteiro,et al.  Response to Comment on “Mast Cell-Mediated Remodeling and Fibrinolytic Activity Protect against Fatal Glomerulonephritis” , 2006, The Journal of Immunology.

[165]  Z. Werb,et al.  Stage-Specific Action of Matrix Metalloproteinases Influences Progressive Hereditary Kidney Disease , 2006, PLoS medicine.

[166]  R. Poulsom,et al.  Bone marrow-derived cells do not contribute significantly to collagen I synthesis in a murine model of renal fibrosis. , 2006, Journal of the American Society of Nephrology : JASN.

[167]  Sakae Tanaka,et al.  Tissue-type Plasminogen Activator Acts as a Cytokine That Triggers Intracellular Signal Transduction and Induces Matrix Metalloproteinase-9 Gene Expression* , 2006, Journal of Biological Chemistry.

[168]  Youhua Liu,et al.  Renal fibrosis: new insights into the pathogenesis and therapeutics. , 2006, Kidney international.

[169]  P. Tipping,et al.  A pathogenetic role for mast cells in experimental crescentic glomerulonephritis. , 2005, Journal of the American Society of Nephrology : JASN.

[170]  K. Legate,et al.  ILK, PINCH and parvin: the tIPP of integrin signalling , 2006, Nature Reviews Molecular Cell Biology.

[171]  D. Cha,et al.  High glucose and angiotensin II increase β1 integrin and integrin-linked kinase synthesis in cultured mouse podocytes , 2006, Cell and Tissue Research.

[172]  Tadashi Yamamoto,et al.  Upregulation of nestin, vimentin, and desmin in rat podocytes in response to injury , 2006, Virchows Archiv.

[173]  A. Eddy.  Progression in chronic kidney disease. , 2005, Advances in chronic kidney disease.

[174]  Chuanyue Wu.  PINCH, N(i)ck and the ILK: network wiring at cell-matrix adhesions. , 2005, Trends in cell biology.

[175]  K. Hruska,et al.  Wnt-dependent beta-catenin signaling is activated after unilateral ureteral obstruction, and recombinant secreted frizzled-related protein 4 alters the progression of renal fibrosis. , 2005, Journal of the American Society of Nephrology : JASN.

[176]  C. Pusey,et al.  Antibody blockade of TNF-alpha reduces inflammation and scarring in experimental crescentic glomerulonephritis. , 2005, Kidney international.

[177]  Youhua Liu.  Hepatocyte growth factor in kidney fibrosis: therapeutic potential and mechanisms of action. , 2004, American journal of physiology. Renal physiology.

[178]  Youhua Liu,et al.  Hepatocyte growth factor antagonizes the profibrotic action of TGF-beta1 in mesangial cells by stabilizing Smad transcriptional corepressor TGIF. , 2004, Journal of the American Society of Nephrology : JASN.

[179]  E. Neilson,et al.  Mechanisms of tubulointerstitial fibrosis. , 2010, Journal of the American Society of Nephrology : JASN.

[180]  Youhua Liu.  Epithelial to mesenchymal transition in renal fibrogenesis: pathologic significance, molecular mechanism, and therapeutic intervention. , 2004, Journal of the American Society of Nephrology : JASN.

[181]  R. Mason,et al.  Oncostatin M, a cytokine released by activated mononuclear cells, induces epithelial cell-myofibroblast transdifferentiation via Jak/Stat pathway activation. , 2004, Journal of the American Society of Nephrology : JASN.

[182]  Junwei Yang,et al.  Hepatocyte growth factor suppresses renal interstitial myofibroblast activation and intercepts Smad signal transduction. , 2003, The American journal of pathology.

[183]  R. Kalluri,et al.  BMP-7 counteracts TGF-β1–induced epithelial-to-mesenchymal transition and reverses chronic renal injury , 2003, Nature Medicine.

[184]  Junwei Yang,et al.  Role for integrin-linked kinase in mediating tubular epithelial to mesenchymal transition and renal interstitial fibrogenesis. , 2003, The Journal of clinical investigation.

[185]  Junwei Yang,et al.  Disruption of tissue-type plasminogen activator gene in mice reduces renal interstitial fibrosis in obstructive nephropathy. , 2002, The Journal of clinical investigation.

[186]  Lida Guo,et al.  Regulation of fibronectin matrix deposition and cell proliferation by the PINCH‐ILK‐CH‐ILKBP complex , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[187]  E. Neilson,et al.  Evidence that fibroblasts derive from epithelium during tissue fibrosis. , 2002, The Journal of clinical investigation.

[188]  Junwei Yang,et al.  Blockage of tubular epithelial to myofibroblast transition by hepatocyte growth factor prevents renal interstitial fibrosis. , 2002, Journal of the American Society of Nephrology : JASN.

[189]  C. Cohen,et al.  A chemokine receptor CCR-1 antagonist reduces renal fibrosis after unilateral ureter ligation. , 2002, The Journal of clinical investigation.

[190]  Junwei Yang,et al.  Dissection of key events in tubular epithelial to myofibroblast transition and its implications in renal interstitial fibrosis. , 2001, The American journal of pathology.

[191]  G. Zalba,et al.  Role of NAD(P)H Oxidase , 2001 .

[192]  A. Eddy.  Molecular basis of renal fibrosis , 2000, Pediatric Nephrology.

[193]  F. Strutz,et al.  Basic fibroblast growth factor expression is increased in human renal fibrogenesis and may mediate autocrine fibroblast proliferation. , 2000, Kidney international.